The research will examine serum and urine samples collected by Hirosaki clinical investigators from well-characterized patient and control populations in Japan. Ezose will conduct the glycan analysis at its US laboratories using its proprietary GlycanMap® technology platform.
"This agreement marks another step that scientists at Ezose and in universities are taking together to...
In order to view the entire article, please read your options to the right
If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.
If you are new to NewsRx, you may also take advantage of cost-saving options such as those below to view this article.
View an unlimited number of articles for a day, week, month, etc.
Purchase a bundle of article-viewing-credits that never expire and receive a discount of up to 50%!
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.